Evidence map›Paper›PMID 39376187›Full record

Observational studyHuman vaccines & immunotherapeutics2024

A prospective, observational, multi-center, post-marketing safety surveillance study of the GSK combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, and

Diego Mpia Elenge, Ju Sun Heo, Sung Shin Kim, Yun-Kyung Kim, Jang Hoon Lee, Stebin Xavier, Enas Bahar, Gaël Dos Santos, Adrienne Guignard

Abstract readMulticenter StudyObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Human vaccines & immunotherapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Adverse Events FollowingVaccines · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Diego Mpia ElengeGSK, Wavre, Belgium.ORCID 0000-0002-2054-7287
Ju Sun HeoDepartment of Pediatrics, Korea University College of Medicine, Seoul, South Korea.ORCID 0000-0001-8928-289X
Sung Shin KimDepartment of Pediatrics, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, South Korea.
Yun-Kyung KimDepartment of Pediatrics, Korea University College of Medicine, Seoul, South Korea.
Jang Hoon LeeDepartment of Pediatrics, Ajou University School of Medicine, Suwon, South Korea.ORCID 0000-0003-4765-9948
Stebin XavierGSK, Bangalore, India.
Enas BaharGSK, Wavre, Belgium.
Gaël Dos SantosGSK, Wavre, Belgium.ORCID 0000-0001-8623-3478
Adrienne GuignardGSK, Wavre, Belgium.ORCID 0000-0002-3899-6902

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In South Korea, a combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, and

Indexed as

Diphtheria-Tetanus-Pertussis VaccineHaemophilus InfectionsHaemophilus VaccinesPoliovirus Vaccine, InactivatedProduct Surveillance, PostmarketingVaccines, CombinedDiphtheriaDrug-Related Side Effects and Adverse ReactionsFemaleHaemophilus influenzae type bHumansInfantMalePoliomyelitisProspective StudiesRepublic of KoreaDiphtheria-Tetanus-Pertussis VaccineHaemophilus VaccinesPoliovirus Vaccine, InactivatedVaccines, CombinedVaccines, ConjugateCombined pentavalent vaccinediphtheriaHaemophilus influenzae type bpediatric vaccinationpertussispoliomyelitispost-marketing surveillancesafetySouth Koreatetanus

Identifiers

PMID39376187
PMCPMC11469445

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.